Quantose-IR_medium.jpg

QUANTOSE® IR is a laboratory-developed test (LDT) that assesses insulin resistance. Clinical intervention at the earliest stage of prediabetes could help delay or prevent the onset of type 2 diabetes and other related chronic conditions. Quantose IR is currently available to clinicians in the U.S. and Mexico.

Quantose-IGT_200.jpg

QUANTOSE® IGT is a laboratory-developed test (LDT) that reflects the degree of impaired glucose tolerance (IGT) in an individual - a known risk factor for prediabetes and cardiovascular disease. Prediabetes occurs when blood glucose levels that are higher than normal, but not yet high enough to be diagnosed as diabetes. Our test is designed to easily differentiate IGT from normal glucose tolerance. Quantose IGT is currently available to clinicians in the U.S.

Meta_UDX_logo.jpg

META UDX™ provides detailed metabolic information from one analysis. Clinicians today use the most advanced health information and data analysis available to solve their undiagnosed and most difficult-to-diagnose patient cases. Even if they cannot find answers, doctors need information that will guide their efforts to treat their patients. They recognize the importance of genomic, metabolic and phenotypic information to truly understand human health.

For more information, please contact us at PMinfo@metabolon.com.